PHARMACOKINETICS, IMMUNOGENICITY, AND EXPOSURE–RESPONSE RELATIONSHIPS OF USTEKINUMAB TREATMENT IN PATIENTS WITH CROHN’S DISEASE: RESULTS FROM THE WEEK 48 TREAT TO TARGET VS STANDARD OF CARE ANALYSIS OF THE STARDUST STUDY

Silvio Danese  1     Severine Vermeire  2     Geert R. D'Haens  3     Omoniyi J. Adedokun  4     Julian Panés  5     Axel Dignass  6     Fernando Magro  7     Maciej Nazar     Marjolein Lahaye     Manuela Le Bars     Lioudmila Ni     Daniel R. Gaya     Ivana Bravata     Laurent Peyrin-Biroulet    
1 Humanitas University,Milan,Italy
2 University Hospitals Leuven,Leuven,Belgium
3 University of Amsterdam,Amsterdam,Netherlands
4 Janssen Research & Development,Pennsylvania,United States
5 Hospital Clinic of Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
6 Agaplesion Markus Hospital,Frankfurt/Main,Germany
7 Institute for Molecular and Cel

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing